Catalent Inc (CTLT)
55.86
-0.09
(-0.16%)
USD |
NYSE |
Apr 25, 12:06
Catalent Total Liabilities (Quarterly): 6.301B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.301B |
| September 30, 2023 | 6.182B |
| June 30, 2023 | 6.166B |
| March 31, 2023 | 6.127B |
| December 31, 2022 | 6.235B |
| September 30, 2022 | 5.505B |
| June 30, 2022 | 5.733B |
| March 31, 2022 | 5.69B |
| December 31, 2021 | 5.722B |
| September 30, 2021 | 5.803B |
| June 30, 2021 | 4.838B |
| March 31, 2021 | 4.697B |
| December 31, 2020 | 4.384B |
| September 30, 2020 | 4.306B |
| June 30, 2020 | 4.271B |
| March 31, 2020 | 4.285B |
| December 31, 2019 | 3.873B |
| September 30, 2019 | 3.864B |
| June 30, 2019 | 3.896B |
| March 31, 2019 | 2.872B |
| December 31, 2018 | 2.879B |
| September 30, 2018 | 2.970B |
| Date | Value |
|---|---|
| June 30, 2018 | 3.444B |
| March 31, 2018 | 3.486B |
| December 31, 2017 | 3.382B |
| September 30, 2017 | 2.746B |
| June 30, 2017 | 2.731B |
| March 31, 2017 | 2.642B |
| December 31, 2016 | 2.566B |
| September 30, 2016 | 2.514B |
| June 30, 2016 | 2.455B |
| March 31, 2016 | 2.455B |
| December 31, 2015 | 2.428B |
| September 30, 2015 | 2.459B |
| June 30, 2015 | 2.504B |
| March 31, 2015 | 2.506B |
| December 31, 2014 | 2.546B |
| September 30, 2014 | 2.448B |
| June 30, 2014 | 3.462B |
| March 31, 2014 | 3.491B |
| December 31, 2013 | 3.487B |
| September 30, 2013 | 3.429B |
| June 30, 2013 | 3.360B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.864B
Minimum
Sep 2019
6.301B
Maximum
Dec 2023
5.151B
Average
5.505B
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 53.14B |
| Merck & Co Inc | 69.04B |
| Elanco Animal Health Inc | 8.139B |
| Avrobio Inc | 6.354M |
| Karuna Therapeutics Inc (DELISTED) | 81.97M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.988B |
| Shareholders Equity (Quarterly) | 3.687B |
| Debt to Equity Ratio | 1.358 |
| Current Ratio | 2.481 |
| Net Debt Paydown Yield | -1.97% |